{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:48:09Z","timestamp":1793677689706,"version":"4.5.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ajp.2024.104142","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T23:38:08Z","timestamp":1721691488000},"page":"104142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Clinical High-Risk for Psychosis (CHR-P) circa 2024: Synoptic analysis and synthesis of contemporary treatment guidelines"],"prefix":"10.1016","volume":"100","author":[{"given":"Michele","family":"Poletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Pelizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Preti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3709-4111","authenticated-orcid":false,"given":"Andrea","family":"Raballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ajp.2024.104142_bib1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/0706743717719895","article-title":"Canadian treatment guidelines for individuals at clinical high risk of psychosis","volume":"62","author":"Addington","year":"2017","journal-title":"Can. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2024.104142_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0269881119889296","article-title":"Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British association for psychopharmacology","volume":"34","author":"Barnes","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.ajp.2024.104142_bib3","article-title":"Interventions for prodromal stage of psychosis","volume":"2019","author":"Bosnjak Kuharic","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ajp.2024.104142_bib4","unstructured":"Catalan Agency for Health Technology Assessment and Research. Clinical Practice Guideline for Schizophrenia and Incipient Psychotic Disorder. Roc Boronat, Barcelona, 2009."},{"issue":"2","key":"10.1016\/j.ajp.2024.104142_bib5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/wps.20526","article-title":"Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis","volume":"17","author":"Davies","year":"2018","journal-title":"World Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2024.104142_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1751-7893.2008.00091.x","article-title":"The Italian guidelines for early intervention in schizophrenia: development and conclusions","volume":"2","author":"De Masi","year":"2008","journal-title":"Early Inter. Psychiatry"},{"issue":"6","key":"10.1016\/j.ajp.2024.104142_bib7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/schbul\/sbs105","article-title":"Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial","volume":"38","author":"van der Gaag","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"1-3","key":"10.1016\/j.ajp.2024.104142_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.schres.2013.07.004","article-title":"Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups","volume":"149","author":"van der Gaag","year":"2013","journal-title":"Schizophr. Res"},{"issue":"1-3","key":"10.1016\/j.ajp.2024.104142_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.schres.2013.07.004","article-title":"Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups","volume":"149","author":"van der Gaag","year":"2013","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.ajp.2024.104142_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/eip.12677","article-title":"Attenuated psychotic symptom interventions in youth at risk of psychosis: a systematic review and meta-analysis","volume":"13","author":"Devoe","year":"2019","journal-title":"Early Inter. Psychiatry"},{"key":"10.1016\/j.ajp.2024.104142_bib11","unstructured":"Early Psychosis Guidelines Writing Group and EPPIC National Support Program, Australian Clinical Guidelines for Early Psychosis, 2nd edition update, 2016, Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne."},{"issue":"1","key":"10.1016\/j.ajp.2024.104142_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jamapsychiatry.2023.3850","article-title":"Normative modeling of brain morphometry in clinical high risk for psychosis","volume":"81","author":"ENIGMA Clinical High Risk for Psychosis Working Group","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2024.104142_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamapsychiatry.2013.269","article-title":"The psychosis high-risk state: a comprehensive state-of-the-art review","volume":"70","author":"Fusar-Poli","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.ajp.2024.104142_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/wps.20896","article-title":"Lack of robust meta-analytic evidence to favour cognitive behavioural therapy for prevention of psychosis","volume":"20","author":"Fusar-Poli","year":"2021","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2024.104142_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/schbul\/sbab129","article-title":"Overoptimistic literature and methodological biases favoring cognitive behavioral therapy for the prevention of psychosis","volume":"48","author":"Fusar-Poli","year":"2022","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.ajp.2024.104142_bib16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0004867416641195","article-title":"Royal Australian and New Zealand college of psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders","volume":"50","author":"Galletly","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.ajp.2024.104142_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1192\/S0007125000291423","article-title":"The 'basic' symptoms of schizophrenia","volume":"7","author":"Gross","year":"1989","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.ajp.2024.104142_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.schres.2023.01.008","article-title":"Psychoeducation for individuals at clinical high risk for psychosis: a scoping review","volume":"252","author":"Herrera","year":"2023","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2024.104142_bib19","unstructured":"Huber, G., 1983. Das Konzept substratnaher Basissymptome und seine Bedeutung f\u00fcr Theorie und Therapie schizophrener Erkrankungen [The concept of substrate-close basic symptoms and its significance for the theory and therapy of schizophrenic diseases]. Nervenarzt. 1983 Jan;54(1):23-32. German."},{"issue":"7321","key":"10.1016\/j.ajp.2024.104142_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Insel","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ajp.2024.104142_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1192\/bjp.2020.241","article-title":"Cost and health impacts of adherence to the national institute for health and care excellence schizophrenia guideline recommendations","volume":"218","author":"Jin","year":"2021","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2024.104142_bib22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1176\/ajp.2006.163.5.790","article-title":"Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis","volume":"163","author":"McGlashan","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.ajp.2024.104142_bib23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/archpsyc.59.10.921","article-title":"Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms","volume":"59","author":"McGorry","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2024.104142_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2021.102005","article-title":"Preventive interventions for individuals at ultra high risk for psychosis: an updated and extended meta-analysis","volume":"86","author":"Mei","year":"2021","journal-title":"Clin. Psychol. Rev."},{"issue":"9","key":"10.1016\/j.ajp.2024.104142_bib25","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/eip.13380","article-title":"Implementation of early intervention clinical services within the National Health System in Italy: third wave survey with focus on structures, resources, and fidelity to the evidence-based model","volume":"17","author":"Meneghelli","year":"2023","journal-title":"Early Inter. Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2024.104142_bib26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1176\/appi.ajp.159.5.863","article-title":"Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of interrater reliability and predictive validity","volume":"159","author":"Miller","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2024.104142_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/oxfordjournals.schbul.a007040","article-title":"Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability","volume":"29","author":"Miller","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2024.104142_bib28","unstructured":"NICEGuidelines, Psychosis and schizophrenia in adults: prevention and management Clinical guideline [CG178], 2014."},{"key":"10.1016\/j.ajp.2024.104142_bib29","article-title":"Suvremene terapijske smjernice za lije\u010denje shizofrenije i drugih psihoti\u010dnih poreme\u0107aja","volume":"32.1","author":"Ostoji\u0107","year":"2023","journal-title":"Medicus"},{"key":"10.1016\/j.ajp.2024.104142_bib30","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajp.2024.104142_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbae029","article-title":"Subgroups of clinical high risk for psychosis based on baseline antipsychotic exposure: clinical and outcome comparisons across a 2-year follow-up period","author":"Pelizza","year":"2024","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.ajp.2024.104142_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/HRP.0000000000000266","article-title":"Developmental psychotic risk: toward a neurodevelopmentally informed staging of vulnerability to psychosis","volume":"28","author":"Poletti","year":"2020","journal-title":"Harv. Rev. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2024.104142_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.schres.2010.07.026","article-title":"Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness","volume":"123","author":"Preti","year":"2010","journal-title":"Schizophr. Res"},{"issue":"9687","key":"10.1016\/j.ajp.2024.104142_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(09)61398-2","article-title":"Clinical staging: a new scenario for the treatment of psychosis","volume":"374","author":"Raballo","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ajp.2024.104142_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3371\/CSRP.5.3.6","article-title":"Psychosis risk syndrome and DSM-5: time for a dimensional approach to at-risk mental states?","volume":"5","author":"Raballo","year":"2011","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"1","key":"10.1016\/j.ajp.2024.104142_bib36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1017\/S0033291719003337","article-title":"Overlooking the transition elephant in the ultra-high-risk room: are we missing functional equivalents of transition to psychosis?","volume":"52","author":"Raballo","year":"2022","journal-title":"Psychol. Med"},{"issue":"16","key":"10.1016\/j.ajp.2024.104142_bib37","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1017\/S0033291720004237","article-title":"Meta-analyzing the prevalence and prognostic effect of antipsychotic exposure in clinical high-risk (CHR): when things are not what they seem","volume":"50","author":"Raballo","year":"2020","journal-title":"Psychol. Med"},{"issue":"12","key":"10.1016\/j.ajp.2024.104142_bib38","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jamapsychiatry.2020.1634","article-title":"Attenuated psychosis syndrome or pharmacologically attenuated first-episode psychosis?: An undesirably widespread confounder","volume":"77","author":"Raballo","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.ajp.2024.104142_bib39","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.biopsych.2021.01.020","article-title":"Individualized diagnostic and prognostic models for psychosis risk syndromes: do not underestimate antipsychotic exposure","volume":"90","author":"Raballo","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.ajp.2024.104142_bib40","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1017\/S0033291722001428","article-title":"Do antidepressants prevent transition to psychosis in individuals at clinical high-risk (CHR-P)? Systematic review and meta-analysis","volume":"53","author":"Raballo","year":"2023","journal-title":"Psychol. Med"},{"issue":"14","key":"10.1016\/j.ajp.2024.104142_bib41","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1017\/S0033291723002180","article-title":"Baseline benzodiazepine exposure is associated with greater risk of transition in clinical high-risk for psychosis (CHR-P): a meta-analysis","volume":"53","author":"Raballo","year":"2023","journal-title":"Psychol. Med."},{"key":"10.1016\/j.ajp.2024.104142_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2023.5611","article-title":"ENIGMA brain morphometry in CHR-P-risk enrichment and antipsychotics","author":"Raballo","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ajp.2024.104142_bib43","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2024.0178","article-title":"Baseline antipsychotic dose and transition to psychosis in individuals at clinical high risk: a systematic review and meta-analysis","author":"Raballo","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2024.104142_bib44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2020.02.009","article-title":"Individualized diagnostic and prognostic models for patients with psychosis risk syndromes: a meta-analytic view on the state of the art","volume":"88","author":"Sanfelici","year":"2020","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.ajp.2024.104142_bib45","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.eurpsy.2015.01.013","article-title":"EPA guidance on the early intervention in clinical high risk states of psychoses","volume":"30","author":"Schmidt","year":"2015","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.ajp.2024.104142_bib46","unstructured":"Sistema Nazionale Linee Guida. Linea guida del Sistema Nazionale Linee Guida. Gli interventi precoci nella schizofrenia. SNLG Documento 14, 2007 (agg. 2009)."},{"issue":"1","key":"10.1016\/j.ajp.2024.104142_bib47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/eip.12443","article-title":"Research and practice for ultra-high risk for psychosis: a national survey of early intervention in psychosis services in England","volume":"13","author":"Stain","year":"2019","journal-title":"Early Inter. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2024.104142_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/eip.13133","article-title":"Omega-3 fatty acid in ultra-high-risk psychosis: a systematic review based on functional outcome","volume":"16","author":"Susai","year":"2022","journal-title":"Early Inter. Psychiatry"},{"issue":"6","key":"10.1016\/j.ajp.2024.104142_bib49","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/appi.ajp.2015.15050618","article-title":"Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia: an observational follow-up study","volume":"173","author":"Tiihonen","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.ajp.2024.104142_bib50","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00787-021-01897-1","article-title":"Evaluating the tendencies of community practitioners who actively practice in child and adolescent psychiatry to diagnose and treat DSM-5 attenuated psychotic syndrome","volume":"31","author":"Yilmaz Kafali","year":"2022","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2024.104142_bib51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/schbul\/22.2.353","article-title":"The prodromal phase of first-episode psychosis: past and current conceptualizations","volume":"22","author":"Yung","year":"1996","journal-title":"Schizophr. Bull."},{"issue":"11-12","key":"10.1016\/j.ajp.2024.104142_bib52","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/j.1440-1614.2005.01714.x","article-title":"Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states","volume":"39","author":"Yung","year":"2005","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.ajp.2024.104142_bib53","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1017\/S0033291720000653","article-title":"The DSM-5 proposal for attenuated psychosis syndrome: a history","volume":"50","author":"Zachar","year":"2020","journal-title":"Psychol. Med"},{"issue":"1","key":"10.1016\/j.ajp.2024.104142_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/schbul\/sbab044","article-title":"Cognitive behavioral therapy for prodromal stage of psychosis-outcomes for transition, functioning, distress, and quality of life: a systematic review and meta-analysis","volume":"48","author":"Zheng","year":"2022","journal-title":"Schizophr. Bull."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201824002351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201824002351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T06:13:32Z","timestamp":1726380812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201824002351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":54,"alternative-id":["S1876201824002351"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2024.104142","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical High-Risk for Psychosis (CHR-P) circa 2024: Synoptic analysis and synthesis of contemporary treatment guidelines","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2024.104142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104142"}}